DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Schramm C, Hirschfield G, Mason A. , et al.
Early assessment of safety and efficacy of tropifexor, a potent non bile-acid FXR agonist, in patients with primary biliary cholangitis: an interim analysis of an ongoing phase 2 study.
J Hepatol 2018;
68: S103
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.